(Reuters) – Synairgen Plc (SYNG.L) said Monday that his drug helped reduce the risk of serious cases in hospitalized patients with COVID-19, according to data from a trial of more than 100 people in the UK, which triggered his actions. The trial, which used interferon beta, showed that patients who …
Read More »Twitter stepped up search to complete top security job before hacking
(Reuters) – Twitter Inc (TWTR.N) had intensified its search for an information security chief in recent weeks, two people familiar with the effort told Reuters, before the high-profile account breach on Wednesday raised alarm about the platform’s security. The FBI’s San Francisco division is leading an investigation into Twitter’s hacking, …
Read More »Moderna shares leaps in data from first coronavirus vaccine trial
(Reuters) – Moderna Inc’s (MRNA.O) Stocks increased by about 11% on Wednesday after a small-scale study showed that its experimental COVID-19 vaccine produced high levels of virus-killing antibodies, raising hopes that the vaccine could be effective in later stages of testing. FILE PHOTO: A sign marks the headquarters of Moderna …
Read More »Modern Phase 1 results show that the coronavirus vaccine is safe and induces an immune response
CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. The volunteers who received two doses of the vaccine had high levels of anti-virus antibodies that exceeded …
Read More »Modern Phase 1 results show that the coronavirus vaccine is safe and induces an immune response
CHICAGO (Reuters) – Moderna Inc’s (MRNA.O) The experimental vaccine for COVID-19 was shown to be safe and elicited immune responses in all 45 healthy volunteers in an early-stage study, US researchers reported Tuesday. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a coronavirus vaccine, in …
Read More »